Government
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 15, 2020.
The investigators assayed the levels and analyzed the expression patterns of more than 3,000 proteins in brain and cerebrospinal fluid samples collected at centers across the U.S.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
The U.S. Food and Drug Administration granted emergency use authorization to Rutgers’ RUCDR Infinite Biologics for its test that uses saliva.
The Stanford serology test provides results in two to three days and Stanford Health Care can test 500 samples per day. Know what more it has to offer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
“We are pleased by the FDA’s approval of Braftovi in combination with cetuximab, as we are committed to developing targeted medicines that can help people living with certain mutation-driven cancers,” said Chris Boshoff, chief development officer, Oncology, Pfizer Global Product Development.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
The designation will allow the company to expedite the development and potential regulatory review of sotatercept.
PRESS RELEASES